1. ALLA AKTIER
  2. NYHETER
  3. BONESUPPORT

Bonesupport

Nyheter Bonesupport Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Invitation to BONESUPPORT™ Capital Markets Day

BONESUPPORT HOLDING AB (publ), a leader in orthobiologics for the management of bone injuries, will arrange a Capital Markets Day (CMD) for investors, analysts and the media on Tuesday, May 26, 2026, 12:30-17:00 pm CEST.

The focus of the CMD will be around the execution of the segment-based strategy to optimize penetration and market share of CERAMENT® within prioritized indication areas. CEO Torbjörn Sköld and other members from the management team will present and answer questions. Two key opinion leaders (KOLs) in orthopedics, in revision arthroplasty and trauma respectively, will present their clinical experiences of CERAMENT.

The event will be held at the Helio, GT30 Grev Ture, room Bond, Grev Turegatan 30 i Stockholm. The CMD will also be broadcast live. To participate please register here: https://bonesupport.events.inderes.com/cmd-2026

The event will be available afterwards on the BONESUPPORT website.

For more information contact:

BONESUPPORT Holding AB
Torbjörn Sköld, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to 1,175 msek in 2025. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

Invitation to BONESUPPORT™ Capital Markets Day

Datum 2026-04-30, kl 08:56
Källa MFN
Bifogade filer
Invitation to BONESUPPORT™ Capital Markets Day